I believe IPIX will hit all 3 milestones by 9/30/18 but in doing so could make the Aspire milestone payments unnecessary. The agreement takes the average price over the previous 5 days as the price that Aspire pays and the share price has to be a minimum of 50 cents. Any milestone announcement on Monday 9/10/18 for example would take the average closing price of the 5 trading days this week which would be around .435 or under the .50 minimum. I believe this is why the MM’s and others are trying their best to keep the share price under 50 cents but they are in a losing battle. A 5 day average share price under 50 cents at the time of milestone announcements is NOT a bad thing for shareholders. For example let’s say IPIX announces a BP royalty deal early next week that included $50M upfront with a 10-15% royalty of worldwide sales plus funding for a Brilacidin phase 3 study. If IPIX received $50M upfront or the equivalent of 4+ years of their current operating expenses why would IPIX want to sell an additional $5M worth of shares at a ridiculously low price with further dilution especially if IPIX share price gaps up to $3+ the day of the announcement? I personally believe that Leo drew the line in the sand for 9/30/18 as a strong statement that the 3 milestones or events will indeed happen but as they come to fruition the funding associated with these milestones will not be needed. JMHO
(5)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links